New turkish questionnaire aims to improve care for breathing machine users
NCT ID NCT07610122
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study checks if a Turkish version of a questionnaire called S3-NIV is reliable and accurate for people with chronic breathing failure who use a home breathing machine. Researchers will ask 120 stable patients to fill out the questionnaire to see how well it measures their difficulties and compliance. The goal is to provide a useful tool for doctors and patients in Turkey.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital
Istanbul, 34854, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••